Carisma Therapeutics Statistics
Total Valuation
CARM has a market cap or net worth of 2.09 million. The enterprise value is 77,253.
| Market Cap | 2.09M |
| Enterprise Value | 77,253 |
Important Dates
The last earnings date was Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CARM has 41.85 million shares outstanding. The number of shares has increased by 1.84% in one year.
| Current Share Class | 41.85M |
| Shares Outstanding | 41.85M |
| Shares Change (YoY) | +1.84% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 10.82% |
| Owned by Institutions (%) | 13.27% |
| Float | 30.14M |
Valuation Ratios
The trailing PE ratio is 0.26.
| PE Ratio | 0.26 |
| Forward PE | n/a |
| PS Ratio | 0.04 |
| PB Ratio | -2.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.01 |
| EV / Sales | 0.00 |
| EV / EBITDA | 0.00 |
| EV / EBIT | 0.01 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.86
| Current Ratio | 0.86 |
| Quick Ratio | 0.65 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.04 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 33.03% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -4,979.46% |
| Revenue Per Employee | 1.14M |
| Profits Per Employee | 174,826 |
| Employee Count | 46 |
| Asset Turnover | 2.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.05% in the last 52 weeks. The beta is 3.69, so CARM's price volatility has been higher than the market average.
| Beta (5Y) | 3.69 |
| 52-Week Price Change | -94.05% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.27 |
| Relative Strength Index (RSI) | 40.73 |
| Average Volume (20 Days) | 324,997 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, CARM had revenue of 52.63 million and earned 8.04 million in profits. Earnings per share was 0.19.
| Revenue | 52.63M |
| Gross Profit | 25.28M |
| Operating Income | 12.85M |
| Pretax Income | 8.04M |
| Net Income | 8.04M |
| EBITDA | 14.18M |
| EBIT | 12.85M |
| Earnings Per Share (EPS) | 0.19 |
Balance Sheet
The company has 2.78 million in cash and 762,000 in debt, giving a net cash position of 2.02 million or 0.05 per share.
| Cash & Cash Equivalents | 2.78M |
| Total Debt | 762,000 |
| Net Cash | 2.02M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | -867,000 |
| Book Value Per Share | -0.02 |
| Working Capital | -942,000 |
Cash Flow
| Operating Cash Flow | -22.42M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 48.03%, with operating and profit margins of 24.41% and 15.28%.
| Gross Margin | 48.03% |
| Operating Margin | 24.41% |
| Pretax Margin | 15.28% |
| Profit Margin | 15.28% |
| EBITDA Margin | 26.94% |
| EBIT Margin | 24.41% |
| FCF Margin | n/a |
Dividends & Yields
CARM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.84% |
| Shareholder Yield | -1.84% |
| Earnings Yield | 384.37% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CARM has an Altman Z-Score of -43.88 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -43.88 |
| Piotroski F-Score | 4 |